4-hydroxycyclophosphamide has been researched along with cladribine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bontemps, F; Cardoen, S; Delacauw, A; Deneys, V; Ferrant, A; Gillis, E; Leveugle, P; Louviaux, I; Scheiff, JM; Van den Berghe, G; Van Den Neste, E | 1 |
1 other study(ies) available for 4-hydroxycyclophosphamide and cladribine
Article | Year |
---|---|
Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cladribine; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Time Factors; Tritium; Tumor Cells, Cultured | 1999 |